Absci Corp reports results for the quarter ended December 31 - Earnings Summary

• Absci Corp ABSI.OQ reported a quarterly adjusted loss of 25 cents​​ per share for the quarter ended December 31, identical to the same quarter last year. The mean expectation of nine analysts for the quarter was for a loss of 24 cents per share. Wall Street expected results to range from -27 cents to -19 cents per share.

• Revenue rose 96.7% to $665.00 thousand from a year ago; analysts expected $1.78 million.

• Absci Corp's reported EPS for the quarter was a loss of 25 cents​.

• The company reported a quarterly loss of $28.98 million.

• Absci Corp shares had risen by 22.5% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Absci Corp is $9.00

This summary was machine generated from LSEG data March 18 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)